Bionano Genomics (BNGO) Profit After Tax (2017 - 2026)

Bionano Genomics has disclosed Profit After Tax across 10 years of filings, most recently posting -$7.4 million for Q2 2026.

• In Q2 2026, Profit After Tax fell 8.25% year-over-year to -$7.4 million; the TTM figure through Jun 2026 stood at -$32.2 million (up 56.73% YoY), while the FY2025 annual figure was -$26.4 million, up 76.44% from the prior year.
• Profit After Tax came in at -$7.4 million for Q2 2026 at Bionano Genomics, up from -$8.3 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$3.1 million in Q1 2025 to a low of -$112.6 million in Q3 2023.
• Average Profit After Tax over 5 years is -$28.8 million, with a median of -$30.7 million recorded in 2022.
• Year-over-year, Profit After Tax plunged 253.88% in 2023 and soared 90.13% in 2025.
• Over 5 years, Profit After Tax stood at -$38.7 million in 2022, then retreated by 13.48% to -$43.9 million in 2023, then surged by 54.15% to -$20.1 million in 2024, then jumped by 60.58% to -$7.9 million in 2025, then advanced by 6.43% to -$7.4 million in 2026.
• Per Business Quant data, the three most recent Profit After Tax figures were -$7.4 million in Q2 2026, -$8.3 million in Q1 2026, and -$7.9 million in Q4 2025.